Table 2 Second screening results in male trap lines.

From: Development of an efficient screening system to identify novel bone metabolism-related genes using the exchangeable gene trap mutagenesis mouse models

No

Gene Symbol

Genotype

Growth Curve

Blood Test

Bone X-gal Staining

Bone Morphometric Analysis

 

BMD Analysis

Cortical Bone Analysis

Trabecular Bone Analysis

Biomechanical Strength Analysis

Tb.BMD

Tb.BMC

Ct.BMD

Ct.BMC

Ct.V

Ct.Th

Ex.Ln.Le

BV

Tb.Th

Tb.N

V*m.space

M.load

M.stress

M.dsp

M.work

E.M.

1

Bptf

WT/Het

+

+

  

 

        

2

New

WT/Hom

  

+

            

   

3

New

WT/Hom

   

  

 

     

4

EST

WT/Hom

+

  

     

    

 

 

5

Apobec1

WT/Hom

 

+

+

  

       

 

   

6

Reep3

WT/Hom

 

+

            

  

 

7

Trp53cor1

WT/Hom

+

                 

8

Lpar5

WT/Hom

+

                 

9

Ankrd11

WT/Het

 

+

+

          

     

10

Lima1

WT/Hom

+

 

 

  

 

11

Cnn3

WT/Het

 

+

+

     

          

12

Wdr11

WT/Hom

 

+

              

 

13

Tctn1

WT/Het

  

+

 

     

 

   

  

14

2500002B13 Rik; lincRNA

WT/Hom

 

+

+

   

          

15

EST

WT/Hom

 

+

                 

16

Msi2

WT/Hom

+

+

 

 

 

17

Wdfy1

WT/Hom

 

+

          

  

  

18

Nedd4

WT/Het

+

+

   

           

19

Tmem161a

WT/Hom

 

+

     

     

   

20

Mark3

WT/Het

+

+

     

    

     

21

Cyb5b

WT/Het

 

+

                 

22

EST

WT/Hom

+

   

    

        

23

Pkig

WT/Hom

+

+

 

 

 

   

 

24

Brd1

WT/Het

+

+

  

             

25

Fbxo17

WT/Hom

 

+

               

 

26

4933407K13 Rik; uncRNA

WT/Het

 

+

                 

27

Epb4.1l2

WT/Hom

+

+

      

    

   

28

New

WT/Hom

  

+

                

29

Cirh1a

WT/Het

 

+

                 

30

New

WT/Hom

+

+

  

 

 

  

31

Etf1

WT/Het

 

+

+

  

  

       

 

32

Ywhag

WT/Het

 

+

+

                

33

Hdac4

WT/Het

            

     

34

Lbr

WT/Hom

+

+

 

 

 

 

  

35

Umps

WT/Het

  

+

          

     

36

Rcl1

WT/Het

  

+

         

      

37

1600020E01 Rik; lincRNA

WT/Het

 

+

+

      

   

    

38

Dym

WT/Hom

 

+

+

   

       

  

39

Ptpn11

WT/Het

+

+

       

 

 

  

40

Slc38a2

WT/Hom

+

+

     

         

41

Ndufaf1

WT/Het

+

   

  

       

 

42

D19Wsu162e

WT/Hom

+

+

                

43

Ppat

WT/Het

+

+

  

             

44

Slc38a4

WT/Het

+

+

             

 

45

EST

WT/Het

+

+

      

 

   

   

46

P4hb

WT/Hom

+

+

 

 

 

    

47

Osbpl8

WT/Hom

 

+

 

   

 

 

  

 

48

Rbm12

WT/Hom

 

+

+

       

        

49

Itpr1

WT/Het

 

+

     

  

       

50

Ctnnd1

WT/Het

+

+

             

  

51

Srr

WT/Hom

            

 

  

52

RhoA

WT/Het

                   
  1. WT: wild-type, Het: Heterozygote, Hom: Homozygote, Tb.BMD: trabecular bone mineral density, Tb.BMC: trabecular bone mineral content, Ct.BMD: cortical bone mineral density, Ct.BMC: cortical bone mineral content, Ct.V: cortical bone volume, Ct.Th: cortical bone thickness, Ex.Ln.Le: external line length, BV: trabecular bone volume, Tb.Th: trabecular bone thickness, Tb.N: trabecular bone number, V*m.space: marrow space star volume, M.load: maximum load, M.stress: maximum stress, M.dsp: maximum displacement, M.work: maximum work, E.M: elastic modulus. +: abnormal blood test results, positive X-gal staining, ↑: > [WT mean + 2.0 SD], ↓: < [WT mean − 2.0 SD], “R” line has not been registered with the EGTC database.